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Background: Poorly differentiated clusters (PDCs) at the invasive front of tumors in colorectal cancer (CRC) have
recently been highlighted as histological prognosticators. We aimed to assess the clinical importance of extent of
PDCs in CRC.
Methods: A total of 239 patients with non-mucinous pT2 and pT3 CRC were pathologically reviewed. PDCs were
defined as cancer clusters composed of ≥5 cancer cells lacking full glandular formation. Patients were classified
according to the number of PDCs observed under a × 20 objective lens. Patients with <5 clusters were classified as
G1, those with 5 to 9 clusters were classified as G2, and those with ≥10 clusters were classified as G3. In addition, in
order to semi-quantitatively evaluate the PDCs, the extent of the highest grade of PDCs at the tumor’s invasive front
was measured and summated, if separately distributed. We identified cutoffs for the extents of PDCs and compared
the results with the patients’ survival rates.
Results: The number of patients with G1, G2, and G3 clusters was 140, 46, and 53, respectively. The presence of G3
PDCs was significantly correlated with lymphatic permeation (P < 0.0001) and node involvement (P < 0.0001). The
5-year overall survival rates of G1, G2, and G3 were 91%, 88%, and 76%, respectively. Based on the Kaplan-Meier
method, 5- and 10-mm cutoffs were identified as the statistically reliable stratification for the extents of G3 clusters,
and 15, 20, and 18 G3 patients exhibited extents of <5 mm, 5 to 9 mm, and ≥10 mm, respectively; however, cutoffs
for the extents of G1 and G2 clusters were not obtained. In the subgroup analysis, when the extents of G3 clusters
were subclassified into <5 mm as G3a, 5 to 9 mm as G3b, and ≥10 mm as G3c, the 5-year overall survival rates were
83%, 62%, and 44%, respectively.
Conclusions: G3 PDCs were highly indicative of tumor aggressiveness. Quantitative evaluation that takes into
account the extent of PDCs would provide more concise prognostic information. Our results suggest that G3 PDCs
with a larger extent are closely associated with unfavorable patient outcome.
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The incidence of colorectal carcinoma (CRC) is on the
rise worldwide, and the mortality and morbidity rates
are high in both men and women [1]. Current thera-
peutic strategies for CRC are based on curative surgery
and postoperative adjuvant chemotherapy. However, it
has been reported that despite curative surgery, colo-
rectal metastatic disease still leads to death in approxi-
mately 30% of cases [2]. As such, early identification
of postoperative recurrent risk is critical for the deter-
mination of appropriate intervention strategies and for
the improvement of patient outcomes.
Since Dukes [3] first reported the histological grad-
ing of rectal cancer in 1932, factors such as depth of
tumor invasion, regional lymph node involvement, and
remote metastasis have been universally accepted as
clinical predictors of CRC [4,5]. Recently, Ueno et al.
[6] were the first to describe poorly differentiated
components or poorly differentiated clusters (PDCs) in
CRC, and their clinical usefulness was also reported in
patients with invasive breast cancer [7]. Thus, further
examination of PDCs could bring a complementary
approach to the pathological diagnostic process ofFigure 1 Tumors assigned into three grades depending on the numb
(a) For G1, four clusters are observed; (b) for G2, six clusters are observed r
observed under × 20 objective lens (0.950 mm2 field of vision). The scale baCRC. PDCs are defined as cancer clusters composed
of more than five cancer cells, present at the invasive
front of a tumor, and lacking full glandular formation
[6]. Although tumor dedifferentiation and dissociation
have been histologically regarded as important first steps
in tumor cell invasion [8], some recent reports docu-
mented that PDCs of CRC were closely associated with
lymph node involvement and could provide a useful
histological indication for tumor cell invasion [9-11].
However, only limited data concerning PDCs [9] have
successfully clarified their impact on long-term patient
outcomes; further validation is still needed. It has been
well-established that histological intratumoral heterogen-
eity increases as a tumor progresses [12]. However, to
date, the clinical significance of varying extents of PDCs -
such as extensively distributed lower grade PDCs or
locally contained higher grade PDCs - has not been fully
investigated. Further understanding of PDCs’ extent
would contribute to the improvement and standardi-
zation of the diagnosis of CRC. In the present study, we
expanded upon the existing PDC scoring system [8] and
assessed how the extents of PDCs are associated with the
clinical outcome of CRC patients.er of PDCs. Arrowheads indicate poorly differentiated clusters (PDCs).
egardless of cluster size; and (c) for G3, more than ten clusters are
r indicates 100 micrometers.
Table 1 Patient characteristics (n = 239)
Parameters Value
Sex (n (%)) Male 131 (55)
Female 108 (45)
Age (mean (range, SD)) 66.7 (23 to 87, 10.3)
Tumor location (n (%)) Colon 147 (62)
Rectum 92 (38)
Depth (n (%)) pT2 63 (26)
pT3 176 (74)
Lymph node involvement (n (%)) pN0 146 (61)
pN1 75 (31)
pN2 18 (8)
Total number of retrieved lymph nodes
(mean (range, SD))
15.6 (0 to 61, 9.77)
Lymphatic permeation (n (%)) Positive 138 (58)
Negative 101 (42)
Venous infiltration (n (%)) Positive 127 (53)
Negative 112 (47)
Adjuvant chemotherapy (n (%)) With 119 (50)
Without 96 (40)
Unknown 24 (10)
PDCs grade (n (%)) G1 140 (59)
G2 46 (19)
G3 53 (22)
SD: standard deviation, PDC: poorly differentiated cluster.
Figure 2 Exemplification of measurement method. PDCs: poorly differentiated clusters. For example, if the extents of the highest PDCs grade
of ‘a’, ‘b’, and ‘c’ are distributed separately, they were summated as the final PDC extent for the analysis.
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Patients
Data from consecutive patients with non-mucinous
pT2 and pT3 CRC [4] who had undergone potentially
curative resection and were enrolled from 2000 to
2005 were used. The exclusion criteria of this retro-
spective cohort were as follows: (1) synchronous or
multiple cancers, (2) preoperative chemotherapy, (3)
cancers related to ulcerative colitis or Crohn’s disease,
and (4) familial adenomatous polyposis or hereditary
non-polyposis colorectal cancer.
The sectioning procedure applied to resected speci-
mens after formalin fixation was performed according
to the Japanese guidelines [5]. In brief, each specimen
was sectioned in a crosswise direction to include the
central part of the tumor. When smaller tumors were
examined, the specimen was step-sectioned at ap-
proximately 5-mm intervals parallel to the long axis of
the intestinal tract. The slides were then stained using
a conventional hematoxylin and eosin staining proced-
ure. A total of three to four slides per specimen were
obtained.
Written informed consent was obtained from all the
patients prior to the initiation of this study, and this
retrospective study was approved by the Institutional
Review Board at the Kyoto Prefectural University of
Medicine (ERB-C-41).
Histopathological evaluation
All slides were pathologically reviewed by a trained
gastrointestinal-specialized pathologist. Based on previ-
ously set definitions [9], PDCs were defined as cancer
clusters composed of ≥5 cancer cells lacking full glandular
formation and identified at the invasive front of tumors.
Tumors were assigned into three grades depending on the
number of PDCs most commonly observed under a × 20
objective lens: G1 had <5 clusters; G2 had 5 to 9 clus-
ters; and G3 had ≥10 clusters (Figure 1). Furthermore,
we assessed the total extent of the highest PDC gradeat the invasive front of the tumors in order to semi-
quantitatively evaluate the significance of PDCs. In
short, even when various grades of PDCs were ob-
served within the same tumor, only the extent of the
highest PDC grade was measured. When the highest
PDC grade was separately distributed, the extents were
summated (Figure 2). Finally, cutoffs for the extent of
each PDC grade were identified, and a subgroup ana-
lysis was performed. For detection of lymphovascular
invasion (LVI), D2-40 antibody (DAKO Cytomation,
Figure 3 Overall survival curves. (a) Overall survival curves according to
(b) according to subclassified G3 PDCs (right).
Table 2 Correlation between PDC grade and
clinicopathological parameters
Parameters PDC grade P value
G1 G2 G3
Sex (n (%)) Male 75 (31) 28 (12) 28 (12) 0.65
Female 65 (27) 18 (8) 25 (10)
Age (n (%)) ≥65 52 (22) 10 (4) 25 (10) 0.031
<65 88 (37) 36 (15) 28 (12)
Tumor location (n (%)) Colon 84 (35) 29 (12) 34 (15) 0.84




Depth (n (%)) pT2 43 (18) 10 (4) 10 (7) 0.26
pT3 97 (40) 36 (15) 43 (18)
Lymph node involvement
(n (%))
pN0 98 (41) 28 (12) 20 (9) <0.0001
pN1 40 (17) 15 (6) 20 (8)
pN2 2 (1) 3 (1) 13 (5)





Positive 74 (31) 16 (7) 42 (17) <0.0001
Negative 66 (28) 30 (13) 11 (5)
Venous infiltration (n (%)) Positive 73 (31) 19 (8) 19 (8) 0.095
Negative 67 (28) 27 (11) 34 (14)
Adjuvant chemotherapy
(n (%))
With 63 (26) 27 (11) 29 (12) 0.22
Without 63 (26) 14 (6) 19 (8)
Unknown 14 (6) 5 (2) 5 (2)
PDC: poorly differentiated cluster.
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lymphatic permeation and vascular infiltration, respect-
ively, according to the recommendations of the Japanese
guidelines [5].
Statistical analysis
Overall survival (OS) curves were plotted using the
Kaplan-Meier method, and comparisons were performed
using a log-rank test. The cutoff for the extents of the
PDCs was optimized by maximizing the significance. A
multivariate Cox proportional hazards regression ana-
lysis was used to assess the prognostic value of PDCs. A
hazard radio (HR) and 95% confidence interval (CI) were
determined using the Cox regression model. All statistical
analyses were performed using Stat View 5.0 software
(SAS Institute, Cary, NC, USA), and a P value of <0.05
was considered statistically significant.
Results
A total of 239 patients were eligible for pathological
review. Patient characteristics are summarized in
Table 1. The median follow-up period after surgery
was 65.3 months (range, SD: 0.33 to 132.6, 34.5), and
the 5-year OS rates were 91%, 87%, and 76% in stage I,
stage II, and stage III, respectively. Since laparoscopic
surgery was not widespread during the period of this
study, operative procedures consisted of laparotomic
interventions only. Based on the highest PDC grades
observed in the tumor specimens, 140 patients (58.6%)
were assigned as G1, 46 (19.2%) as G2, and 53 (22.2%)
as G3. As shown in Table 2, G3 PDCs were signifi-
cantly correlated with older age (≥65 years, P = 0.031),the highest poorly differentiated cluster (PDC) grade (left) and
Table 3 Univariate and multivariate survival analyses of representative histopathological variables
Parameters Univariate Multivariate
Hazard ratio 95% CI P value
Age (≥65 vs. <65) 0.55 1.02 0.54 to 1.91 0.9495
Tumor location (colon vs. rectum) 0.80 1.16 0.61 to 2.21 0.6517
Depth (pT3 vs. pT2) 0.38 1.19 0.56 to 2.53 0.6463
Lymph node involvement (pN1-2 vs. pN0) 0.036 1.35 0.70 to 2.60 0.3758
PDC grade (G3 vs. G1-2) <0.0001 3.21 1.67 to 6.20 <0.0005
CI: confidence interval, PDC: poorly differentiated cluster.
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involvement (P < 0.0001). No significant differences
were found in the clinicopathological factors between
the colon and rectal carcinomas. When representative
clinicopathological variables were evaluated by univar-
iate analysis, lymph node involvement (P = 0.036) and
G3 PDCs (P < 0.0001) were found to be significantly
associated with short survival. As shown in Figure 3a, the
5-year OS rates of G1, G2, and G3 PDCs were 91%, 84%,
and, 66%, respectively. Furthermore, multivariate analysis
showed that G3 was the most reliable prognostic factor
(Table 3).
By using the Kaplan-Meier method for achieving the
most statistically efficient discrimination for the pa-
tients’ prognoses, cutoffs of 5 mm (P = 0.018) and
10 mm (P = 0.048) for the extent of G3 PDCs were identi-
fied; however, no significant cutoffs for PDCs’ extents were
obtained for G1 and G2 PDCs (Table 4). Figure 4 breaks
down the stratification of the patients based on the extent
of PDCs in each grade; 137, 2, and 1 G1 patients; 29, 12,
and 5 G2 patients; and 15, 20, and 18 G3 patients exhib-
ited extents of <5 mm, 5 to 9 mm and ≥10 mm, respect-
ively. When the extent of G3 was subclassified into
<5 mm as G3a, 5 to 9 mm as G3b, and ≥10 mm as G3c,
subgroup analyses of G3 cases demonstrated that the 5-
year OS rates of G3a, G3b, and G3c were 83%, 62%, andTable 4 Evaluation of the cutoff value for extent of G3
PDCs
Extent of G3 PDCs P value
<10 mm vs. ≥10 mm 0.32
<9 mm vs. ≥9 mm 0.27
<8 mm vs. ≥8 mm 0.27
<7 mm vs. ≥7 mm 0.16
<6 mm vs. ≥6 mm 0.027
<5 mm vs. ≥5 mm 0.0043
<4 mm vs. ≥4 mm 0.018
<3 mm vs. ≥3 mm 0.019
<2 mm vs. ≥2 mm 0.035
<1 mm vs. ≥1 mm 0.16
PDCs: poorly differentiated clusters.44%, respectively (Figure 3b). Additionally, in the sub-
group analysis, the patients who received adjuvant chemo-
therapy vs. those who did not were 10 vs. 5; 8 vs. 12; and
11 vs. 7 in G3a, G3b, and G3c, respectively. The 5-year
survival rates were as follows: in G3a: 88% vs. 80%; in G3b:
64% vs. 60%; and in G3c: 42% vs. 49%.Discussion
In the present study, we pathologically examined 239
consecutive patients with non-mucinous pT2 and pT3
CRC in order to (1) validate the clinical importance of
PDCs based on a single institution experience and (2)
demonstrate the extent of PDCs and determine its diag-
nostic importance. To our knowledge, no previous re-
port has documented the diagnostic significance of
extent of PDCs. In this study, we used a highly selective
cohort of CRC. Although previous reports suggested
that mucinous carcinoma may exhibit similar onco-
logical aspects as PDCs [6,13], researchers have not yet
reached a consensus regarding their biological similar-
ities. Therefore, mucinous carcinomas were excluded
from this study.
Our results showed that the presence of G3 PDCs was
significantly correlated with lymphatic permeation and
lymph node involvement and was an unfavorable histo-
logical indicator. These results are in line with prior
reports [6,9-11]. With regard to the assignment of the
highest grade of PDCs, Ueno et al. [9] classified 50%,
30%, and 20% among a total of 3,242 patients with stages
I to III CRC as G1, G2, and G3 PDCs, respectively. In
this study, 59%, 19%, and 22% of patients with pT2-3
non-mucinous CRC were classified as G1, G2, and G3
PDCs, respectively. Our results were comparable to the
aforementioned findings.
Previous methodologies have provided primarily quali-
tative or limited quantitative information, which does
not aptly reflect the extent of PDCs. In this study, we
aimed to clarify the prognostic value of the extents of
PDCs. Our results demonstrated that the extents of G1
or G2 are not strong prognosticators, as we did not
obtain any significant cutoff values for them. That is,
even when G1 and G2 PDCs predominantly distribute,
Figure 4 Stratification of patients based on the extent of each poorly differentiated clusters (PDCs) in each grade.
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any valuable prognostic information. On the other hand,
since our analyses showed a statistically significant cutoff
extent for G3, special consideration should be given to
the extents of G3 PDCs during the diagnostic process.
In other words, G3 PDCs with larger extents are predict-
ive of a very poor survival outcome, whereas the 5-year
OS rate of patients with <5-mm extents of G3 PDCs
(83%) was close to that of G2 patients (88%). These
results suggest that the extents of G3 PDCs could have
a potential impact on patient survival.
This study has a number of limitations. First, because
this was a retrospective cohort study, there was no con-
trol over the type of adjuvant chemotherapy given to
patients, its course, or its completion. However, this
study was also designed to investigate the indication for
adjuvant chemotherapy; as a result, half of the patients
chosen for this study received adjuvant chemotherapy.
In the subgroup analysis of G3 PDCs in which the
patients with and without adjuvant chemotherapy were
compared, no significant differences were found in the
5-year survival rates of the two. A previous report [6]
described similar findings concerning the correlation
between adjuvant chemotherapy and PDCs. Developing
effective adjuvant chemotherapy is challenging and
merits further studies with larger sample sizes. The sec-
ond limitation is that lymphatic permeation (58%) and
vascular infiltration (53%) may have been overestimated
in this group of patients. Although the reason for this is
uncertain, a possible explanation is that the higherdetection rate may have been the result of using multiple
slides for evaluation combined with the routine use of
D2-40 antibody and elastic staining. Many authors have
reported that endothelial markers may help the detec-
tion of LVI; however, interobserver concordance re-
mains low, even among gastrointestinal-specialized
pathologists [14,15].
Conclusions
In conclusion, PDCs are highly indicative of tumor
aggressiveness in non-mucinous pT2 and pT3 CRC. A
more quantitative diagnostic approach to the evaluation
of PDCs which takes into account the extent of PDCs
would provide more concise prognostic information.
Overall, our results suggest that the extents of G3 PDCs
require special attention during diagnosis and that G3
PDCs with larger extents are closely associated with
unfavorable patient outcomes.
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